Johnson & Johnson EVP sells 15K shares after option exercise

JOHNSON & JOHNSON (JNJ) executive Jennifer L. Taubert (EVP, WWC.

Rhea-AI Filing Summary

JOHNSON & JOHNSON (JNJ) executive Jennifer L. Taubert (EVP, WWC. Innovative Medicine) reported an exercise-and-sale transaction involving 15,000 shares. She exercised 15,000 Employee Stock Options to acquire 15,000 shares of Common Stock at $115.67 per share, then sold 15,000 shares of Common Stock at a weighted average price of $263.36 per share in trades between $263.30 and $263.48. Following the option exercise, she held 28,712 derivative securities (stock options) of the issuer directly.

Insider Trade Summary

Exercise and Sale: 15,000 shares ($2.22M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Taubert Jennifer L

Role EVP, WWC. Innovative Medicine

Sold 15,000 shs ($3.95M)

Approx. gross sale proceeds $3.95M

Approx. exercise cost $1.74M

Approx. pre-tax spread $2.22M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Options (Right to Buy) F2	15,000	$0.00	$0.00
Exercise	Common Stock	15,000	$115.67	$1.74M
Sale	Common Stock F1	15,000	$263.36	$3.95M

Holdings After Transaction: Employee Stock Options (Right to Buy) — 28,712 contracts (Direct); Common Stock — 194,451.001 shares (Direct)

Footnotes (2)

1. F1. This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2. F2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Key Figures

Options Exercised: 15,000 shares Option Exercise Price: $115.67 per share Shares Sold: 15,000 shares +3 more

6 metrics

Options Exercised 15,000 shares Employee Stock Options exercised into Common Stock on 2026-08-17

Option Exercise Price $115.67 per share Exercise price of Employee Stock Options converted into Common Stock

Shares Sold 15,000 shares Common Stock sold on 2026-08-17

Weighted Average Sale Price $263.36 per share Sale in multiple trades at prices from $263.30 to $263.48

Remaining Derivative Securities 28,712 options Employee Stock Options held directly after the exercise transaction

Option Expiration Date 2027-02-13 Expiration date of the Employee Stock Options exercised in part

Key Terms

Employee Stock Options, Long-Term Incentive Plan, weighted average sale price

3 terms

Employee Stock Options financial

"Employee Stock Options (Right to Buy)"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

Long-Term Incentive Plan financial

"Awarded under Issuer's Long-Term Incentive Plan."

A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did JNJ executive Jennifer L. Taubert report on this Form 4?

Jennifer L. Taubert reported exercising 15,000 stock options at $115.67 per share to acquire 15,000 JNJ common shares, then selling 15,000 shares at a weighted average price of $263.36 per share in market trades.

At what prices were Jennifer L. Taubert’s JNJ shares sold?

The 15,000 JNJ shares were sold at a weighted average price of $263.36 per share, with individual trades executed at prices ranging from $263.30 to $263.48, as disclosed in the transaction footnote.

What was the exercise price of the JNJ stock options used by Jennifer L. Taubert?

The exercised Employee Stock Options had an exercise price of $115.67 per share, and their exercise resulted in the acquisition of 15,000 shares of Johnson & Johnson Common Stock before the subsequent sale.

How many Johnson & Johnson derivative securities does Jennifer L. Taubert hold after this transaction?

After exercising 15,000 options, Jennifer L. Taubert held 28,712 derivative securities (stock options) of Johnson & Johnson directly, as reported in the post-transaction holdings field for the option position.

What plan were Jennifer L. Taubert’s JNJ stock options granted under?

The options exercised in this filing were awarded under Johnson & Johnson’s Long-Term Incentive Plan. The related footnote states that the Stock Option Award vests and is exercisable on the third anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 06:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taubert Jennifer L

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, WWC. Innovative Medicine

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/17/2026		M		15,000	A	$115.67	209,451.001	D
Common Stock	08/17/2026		S		15,000	D	$263.36(1)	194,451.001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$115.67	08/17/2026		M			15,000	02/13/2020(2)	02/13/2027	Common Stock	15,000	$0	28,712	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)